United Therapeutics (UTHR) Shares Outstanding (2009 - 2026)

United Therapeutics has disclosed Shares Outstanding across 18 years of filings, most recently posting $77.1 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $77.1 million, up 2.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $77.1 million (up 2.57% YoY), and the FY2025 annual result was $43.6 million, down 41.81% from the prior year.
• Shares Outstanding came in at $77.1 million for Q1 2026 at United Therapeutics, up from $43.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $76.5 million in Q4 2025 to a low of $42.2 million in Q1 2026.
• The 5-year median for Shares Outstanding is $73.7 million (2023), against an average of $72.1 million.
• Across the five-year window, Shares Outstanding tumbled 41.81% in 2025 and rose 2.57% in 2026, its largest moves.
• United Therapeutics' Shares Outstanding stood at $72.7 million in 2022, then gained by 1.38% to $73.7 million in 2023, then increased by 1.76% to $75.0 million in 2024, then sank by 41.81% to $43.6 million in 2025, then jumped by 76.73% to $77.1 million in 2026.
• The last three Shares Outstanding figures came in at $77.1 million (Q1 2026), $43.6 million (Q4 2025), and $75.7 million (Q3 2025), per Business Quant data.